OPKO Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by OPKO Health, Inc. on June 13, 2016. The report details a corporate action regarding the transfer of the listing of the Company's common stock from the New York Stock Exchange (NYSE) to the NASDAQ Global Market.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document is strictly a notice of a listing transfer.
Material Changes
- Voluntary Delisting: The Company notified the NYSE of its intention to voluntarily delist its common stock.
- Transfer of Listing: The Company intends to list its common stock on the NASDAQ Global Market.
- Trading Timeline: Trading on the NYSE is expected to cease at market close on June 23, 2016. Trading on NASDAQ is expected to commence on June 24, 2016.
- Symbol Continuity: The common stock will continue to trade under the symbol "OPK".
Guidance, Outlook, and Risks
The filing includes a Regulation FD disclosure referencing a press release (Exhibit 99.1) regarding the transfer. The document does not provide specific management commentary on future financial guidance, operational outlook, or new material risks beyond the execution of the listing transfer. The information in the press release is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Confirm the cessation of NYSE trading on June 23, 2016, and the commencement of NASDAQ trading on June 24, 2016.
- Verify that the ticker symbol remains "OPK" on the new exchange.
- Review the press release (Exhibit 99.1) for any additional context regarding the strategic rationale for the transfer not included in this summary.